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Objective: The purpose of this study was to compare survival and outcomes of endovascular versus open repair of
abdominal aortic aneurysms (AAAs) in New York State (NYS).
Methods: We used the NYS discharge dataset Statewide Planning and Research Cooperative System (SPARCS) to analyze
the outcomes of elective admission for nonruptured (International Classification of Diseases–9th revision [ICD-9]
441.4) open aneurysm repair (38.44) and endovascular aneurysm repair (39.71) during the years 2000-2002. The ICD-9
code for endovascular repair was introduced in late 2000, thus capturing 3 months of empiric data for 2000.
Results: There has been a significant increase in the number of AAA procedures performed in NYS (comparing before and
after 2000: average, 1419 vs 1701; P .0001), temporally coinciding with the implementation of training programs after
US Food and Drug Administration approval of endovascular grafts and the new payment code. From 2000 to 2002 the
number of NYS hospitals performing endovascular repairs increased from 24 to 60. By 2002 there were more
endovascular repairs being performed than open repairs (871 vs 783). The target population for these surgical
interventions showed interesting differences. In 2002, women had a 43% chance of receiving an endograft, whereas men
had a 55% probability. The use of endovascular repair over the observation period was relatively constant in patients
younger than 65 years. In patients older than 65 years, and especially those older than 75 years, endovascular use
increased substantially, so that by 2002 older patients were more likely to undergo endovascular repair than open repair.
Patients who underwent endovascular repair had significantly more hypertension, coronary artery disease, diabetes, and
hyperlipidemia than did patients who underwent open repair. Yet the mean length of stay for endovascular procedures
was approximately 3.6 days, and for open procedures was about 10.3 days, across all 3 years (P  <.0001). Moreover,
patients who underwent endovascular repair had statistically fewer postoperative complications and significantly lower
mortality. In-hospital mortality in 2001 was 3.55% for open repair and 1.14% for endovascular repair (P  .0018), and
in 2002 these rates were 4.21% versus 0.8% (P < .0001), respectively.
Conclusion: This dataset suggests that endovascular AAA repairs are being performed in a patient poplation with a higher
frequency of comorbidities. However, endovascular repairs still are associated with significantly lower in-hospital
mortality, fewer postoperative complications, and a dramatically shorter length of stay. These results suggest that, despite
the rapid diffusion of this new technique, early perioperative outcomes may be superior to those with conventional open
repair. However, prospective clinical studies are needed to confirm these insights, and such studies may require the
infrastructure of consortia of hospitals or society-based registries. (J Vasc Surg 2004;39:10-9.)
Despite advances in technique and perioperative care,
open repair of abdominal aortic aneurysms (AAAs) is still
associated with significant perioperative risk. Large obser-
vational studies as well as multicenter randomized trials
have repeatedly demonstrated mortality rates with open
repair ranging from 1% to 10%.1-6 Consequently, many
patients at high risk with severe coexisting coronary artery
disease or advanced pulmonary disease are not offered
repair. In view of the limitations of open repair, a less
invasive approach to aneurysm exclusion has been pursued.
Four endografts are currently approved by the US Food
and Drug Administration (FDA). Although the long-term
durability and effectiveness of this technique remains some-
what uncertain, endoluminal repair has been embraced
with enthusiasm by both patients and physicians.
It was initially hypothesized that endovascular aneu-
rysm repair would substantially reduce patient discomfort
and dysfunction. Small prospective studies have demon-
strated an earlier return to baseline function, resulting in
reduction in the usual postoperative convalescence time by
at least 1 month.7,8 It was also expected that endovascular
repair would decrease morbidity and mortality, particularly
in patients considered at high risk for aneurysm repair; this
hypothesis, however, has been more difficult to prove.
Although several individual institutions have reported ben-
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efit with regard to mortality for endovascular versus open
repair,9,10 other multicenter trials reveal mortality and
morbidity rates that are equivalent for these two tech-
niques.11-13
Moreover, it has been well-documented in other areas
of vascular intervention that experience and volume are
critical to achieving excellent outcomes. The technique of
endovascular aneurysm repair is demanding, and trials to
date have been carefully confined to centers where there is
particular interest in this approach. Consequently, concerns
have been raised about the transition of endovascular an-
eurysm repair from trial centers to the community at large.
Adding to this concern is that training for two of the most
commonly used FDA-approved grafts involved only 2 days
of instruction, with little or no hands-on experience.
To gain a better understanding of the outcomes of
endovascular repair after release of FDA-approved devices,
we examined the New York State (NYS) hospital discharge
database (Statewide Planning and Research Cooperative
System [SPARCS]) for the years 2000 to 2002. Although
grafts for endovascular aneurysm repair were initially FDA-
approved in 1999, the Health Care Financing Administra-
tion (now Center for Medicare and Medicaid Services) did
not introduce an International Classification of Diseases–
9th revision [ICD-9] procedure code until October 1,
2000. The new ICD-9 code enables tracking of this proce-
dure through state and national hospital discharge data-
bases. In NYS, we were successful in identifying more than
1700 discharges following endovascular aneurysm repair
over 27 months. Consequently, we compared patient char-
acteristics and outcomes of those receiving conventional
aneurysm repair with those of patients undergoing endo-
vascular procedures during the same period.
METHODS
Discharge data for patients who underwent elective
AAA repair between 1995 and 2002 were extracted from
the NYS SPARCS database. Legislatively mandated in the
1970s, this system has been collecting hospital discharge
abstracts for more than 25 years (http://www.health.state.
ny.us/nysdoh/sparcs/sparcs.htm). The database includes
more than 50 million discharges from 1977 to the present,
and it covers about 225 hospitals in the state of New York.
These data are maintained by the New York Department of
Health, and they contain information on every patient
discharged from an acute-care, nonfederal hospital. Ninety-
five percent of the hospital’s SPARCS data must be submit-
ted 60 days following the month of the patient’s discharge
and 100% of the data is due 180 days following the end of
the facility’s fiscal year. This dataset has been used to
support many informative studies of surgical procedures,
including aneurysm repair, cardiovascular interventions,
carotid endarterectomy and cerebral aneurysms repair.14-18
From 1995 to 2000, we analyzed the annual volume of
elective AAA repair; for the years 2000 to 2002 we distin-
guished between open and endovascular repair.
An elective patient population was extracted from the
SPARCS dataset by using “admission type 3” as our first
filter. This variable designates only “elective admissions.”
Next we selected patients on the basis of principal diag-
noses. Patient discharges with the principal diagnosis code
441.4 (Abdominal aneurysm without mention of rupture)
were included, thereby excluding ruptured AAAs and tho-
racoabdominal aneurysms. The type of surgical repair that
patients received was identified by the ICD-9 codes. Pa-
tients discharged after open AAA repairs had a principal
ICD-9 procedure code of 38.44 (Resection of abdominal
aorta with replacement).
The FDA approved both the AneuRx and Ancure grafts
on September 28, 1999. The official ICD-9 procedure
code for endovascular repairs (39.71) was not introduced
until a year later (October 1, 2000), marking the new
federal fiscal year. Before this time the coding of endovas-
cular repairs was extremely variable. Prior to the introduc-
tion of the new ICD-9 code, endovascular repair was often
coded under 38.44 or 39.52 (other repair of aneurysm).
The designation code 39.52 includes coagulation, electro-
coagulation, filipuncture, methyl methacrylate, suture, wir-
ing, and wrapping, and it was excluded from the analysis,
because it contains such a wide range of alternative proce-
dures.
For the per capita calculations, statewide census infor-
mation was obtained from both the National Census Bu-
reau and NYS. The estimated NYS population for 2002 is
19,157,532, whereas the 2001 census cites the population
as 19,084,350. Because specific subgroup estimates are not
available for 2002 (eg, gender, race, age), we used 2001
data for 2002 per capita calculations. The characterization
of hospitals as teaching hospitals was based on the directory
of the Association of Academic Medical Colleges (Wash-
ington, DC), and data for hospital bed size was from the
American Hospital Association.19
Statistical analysis. Proportions were compared with
the 2 test, means were compared with the Student t test,
and medians were compared with nonparametric tests.
When two factors were analyzed simultaneously, a two-
factor analysis of variance was used (PROC GLM, SAS).
Procedure frequencies were analyzed using poisson regres-
sion methods. Results were expressed as both P values and
95% confidence intervals (95% CI). All data were analyzed
with SAS system software (SAS Institute, Cary, NC).
RESULTS
Diffusion of AAA repairs in NYS. The trend in
elective AAA repairs between 1995 and 2002 is shown in
Fig 1. Between 1995 and 2000 the total number of elective
AAA repairs performed in NYS remained relatively stable
(notrend observed, P  .3032). In 2001 the total number
of procedures performed in NYS increased significantly.
This increase temporally coincided with the implementa-
tion of training programs in endovascular repair after FDA
approval of the two endografts and the new endovascular
payment code (ICD-9 code introduced in late 2000).
Comparing the average number of AAA repairs before and
after 2000 (1419 vs 1701), we found a significant increase
(20%; P  .0001). In 2001 40% of all AAA repairs were
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done by the endovascular approach. By 2002, however,
more endovascular procedures were performed than open
procedures (871 vs 783). Per capita rates for AAA repair are
shown in Fig 2.
From 2000 to 2001 the number of NYS hospitals
(approximately 225*) performing endovascular AAA re-
pairs doubled, from 24 to 48, and this number increased to
60 in 2002. During this time, however, the number of
hospitals performing open repairs remained constant: 111
in 2000, 110 in 2001, and 101 in 2002. As the new
technique disseminated, the regional distribution changed
dramatically, whereas the regional distribution for open
repairs remained fairly similar over the study (Fig 3).
NYS has 62 counties. The number of counties perform-
*This number is approximate, because the subdivisions of hospitals are
sometimes listed separately.
Fig 1. Elective repair of abdominal aortic aneurysm. The 2002 data from the New York State Department of Health
Statewide Planning and Research Cooperative System dataset were 95% to 96% complete at the time of analysis.
Cross-hatched bars, Total number of AAAs.
Fig 2. Per capita abdominal aortic aneurysm repairs by year and type. Cross-hatched bars, Total repairs; black bars, open
repairs; white bars, endovascular repairs.
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ing endovascular repair increased from 13 to 23 between
2000 and 2002, and all of the initial 13 counties per-
forming this procedure showed increased volume during
these years.
Sixty-two percent of hospitals performing endovascular
procedures in 2000 were teaching hospitals. As the proce-
dure disseminated to nonacademic centers, this number
decreased to 47% by 2002. In 2000 the endovascular
operation was highly concentrated; 82% of all endovascular
procedures performed in NYS were done in 10 facilities.
However, in 2002 the top 10 hospitals performed only 55%
of endovascular procedures. At the same time, nearly 50%
of hospitals doing endovascular repairs performed five or
fewer procedures annually.
Target population. The demographic characteristics
of the patients undergoing elective AAA repair are shown in
Table I. By far, most endovascular repairs performed dur-
ing these years were in men (82%-83%), white patients
(80%-85%), and patients older than 75 years (48%-52%).
However, during the study period, we were able to observe
population differences in the use of open versus endovas-
cular repair. In 2002, women requiring aneurysm repair
had a 43% chance of receiving an endograft. In contrast,
men had a 55% probability of receiving endovascular repair.
With respect to race, endovascular interventions were used
in over 50% of the AAA repairs performed in both whites
and blacks in NYS. (Whites received 739 endovascular out
of 1434 total repairs, and blacks received 27 endovascular
out of 46 total repairs.) As these numbers indicate, very few
black patients underwent aneurysm repair, which limits our
ability to analyze this subgroup. Last, the use of endovas-
cular repair over the 3 years of observation has been rela-
tively constant in patients younger than 65 years (No trend
observed, P  .2597). In patients older than 65 years, and
especially those older than 75 years, endovascular use in-
creased substantially; thus, by 2002 older patients were
Fig 3. Regional distribution of endovascular repairs.
Table I. Demographic data
2000 2001 2002
Open (PC) Endovascular (PC) Open (PC) Endovascular (PC) Open (PC) Endovascular (PC)
N 1238 (6.7) 131 (0.7) 1043 (5.6) 704 (3.8) 783 (4.25) 871 (4.73)
Sex
Male 77% (10.8) 82% (1.2) 76% (9.0) 83% (6.6) 75% (6.6) 83% (8.2)
Female 23% (3.0) 18% (0.3) 24% (2.6) 17% (1.2) 25% (2.1) 17% (1.6)
Age (y)
15–44 0.5% (0.07) 0% (0.0) 0.3% (0.04) 0% (0.0) 0.4% (0.04) 0% (0.0)
45–64 15% (4.5) 11% (0.4) 15% (3.6) 12% (1.9) 18% (3.3) 12% (2.5)
65–74 44% (43.4) 37% (3.8) 40% (34.1) 40% (23.3) 38% (24.0) 37% (26.1)
75 40% (47.1) 52% (6.4) 45% (43.6) 48% (31.5) 44% (32.0) 51% (41.4)
Race
White 86% (8.3) 82% (0.8) 89% (7.3) 80% (4.4) 89% (5.4) 85% (5.8)
Blacks 3% (1.5) 2% (0.1) 3% (1.0) 2% (0.6) 2% (0.7) 3% (1.0)
PC, Per capita: Number of procedures per 100,000 population.
JOURNAL OF VASCULAR SURGERY
Volume 39, Number 1 Anderson et al 13
more likely to undergo endovascular repair than open
repair (Table I; Increasing trend, P  .0001).
When the most commonly coded preoperative risk
factors were analyzed, the degree of comorbid disease was
found to be higher in patients undergoing endovascular
repairs (Table II). There was a significantly higher rate of
hypertension, coronary artery disease, diabetes mellitus,
and hyperlipidemia in the endovascular group in 2001 and
2002. Because of the limitations of the dataset, two clinical
conditions, atrial fibrillation and congestive heart failure,
cannot be characterized as either a comorbid condition or a
complication of the procedure.
In-hospital mortality and postoperative complica-
tions. In 2000 the dataset contained only 3 months of
endovascular codes. The overall in-hospital mortality rate
was 4.0% (95% CI, 3.1%, 5.2%). For open repairs the
mortality rate was 4.1% (95% CI, 3.1%, 5.1%), whereas for
endovascular repairs this rate was 3.05% (95% CI, 0.8%,
7.6%). The difference in mortality between operative tech-
niques was not significant (95% CI,2.1%, 4.2%; P .55;
Fig 4).
In 2001 the in-hospital mortality rate was 2.6% (95%
CI, 1.9%, 3.4%). The mortality rate for open repairs was
3.6% (95% CI, 2.5%, 4.8%), compared with a mortality rate
of 1.1% (95% CI, 0.5%, 2.2%) for endovascular procedures.
The mortality difference (2.5%) between the procedures
was significant (95% CI, 1.0%, 3.7%; P  .0018). In 2002
the overall in-hospital mortality rate was similar, at 2.4%
(95% CI, 1.7%, 3.3%). For open repairs the mortality rate
was 4.2% (95% CI, 2.9%, 5.9%), whereas the mortality rate
for endovascular procedures was 0.8% (95% CI, 0.3%,
1.7%). The mortality difference (3.4%) between the two
procedures was significant (95% CI, 1.9%, 4.9%; P 
.0001).
The three most commonly coded postoperative com-
plications documented in patients with AAA repair were
acute post-hemorrhagic anemia, pulmonary insufficiency,
and cardiac complications. In both 2001 and 2002, the rate
of these complications was significantly higher in patients
who underwent open procedures (Table III).
Length of stay. There was a marked difference in
length of stay (LOS) for the two procedures. The mean
Table II. Comorbid conditions
Open Endovascular
Relative
risk 95% CI P% n % n
Comorbidities (ICD-9)
2000 N  1237 N  131
COPD (496  4928) 23.0 284 25.2 33 0.91 0.67–1.24 .5614
Hypertension (4019) 41.6 514 55.0 72 0.76 0.64–0.89 .0031
CAD (41401) 21.1 261 22.1 29 0.95 0.68–1.34 .7787
Diabetes mellitus (25000) 7.0 87 9.9 13 0.71 0.41–1.23 .2257
Lipids (2720) 9.0 111 14.5 19 0.62 0.39–0.97 .0398
PVD (4439) 3.8 47 3.1 4 1.24 0.46–3.40 .6694
Smoking or history of smoking (3051) 4.0 50 5.3 7 0.76 0.35–1.63 .4771
2001 N  1043 N  704
COPD (496  4928) 24.4 255 25.6 180 0.98 0.81–1.13 .5956
Hypertension (4019) 45.1 470 54.3 382 0.83 0.75–0.91 .0002
CAD (41401) 18.8 196 24.9 175 0.76 0.63–0.91 .0024
Diabetes mellitus (25000) 7.0 73 10.7 75 0.66 0.48–0.89 .0071
Lipids (2720) 11.9 124 17.9 26 0.66 0.53–0.84 .0004
PVD (4439) 2.5 26 5.3 37 0.47 0.29–0.78 .0024
Smoking or history of smoking (3051) 5.5 58 5.3 37 1.06 0.71–1.58 .7826
2002 N  783 N  871
COPD (496  4928) 25.8 202 25.8 225 1.00 0.85–1.18 .9874
Hypertension (4019) 43.2 338 55.2 481 0.77 0.70–0.86 .0001
CAD (41401) 17.2 135 23.7 209 0.80 0.70–0.92 .0013
Diabetes mellitus (25000) 6.8 53 10.9 95 0.74 0.59–0.92 .0032
Lipids (2720) 12.9 101 19.4 169 0.76 0.64–0.89 .0004
PVD (4439) 2.9 23 3.8 33 0.86 0.63–1.19 .3392
Smoking or history of smoking (3051) 7.2 56 8.5 74 1.09 0.87–1.36 .4750
Associated findings (ICD-9)
2000
Atrial fibrillation (42731) 12.1 150 9.2 12 1.32 0.76–2.32 .3192
CHF (4280) 11.5 142 6.9 9 1.67 0.87–3.20 .1100
2001
Atrial fibrillation (42731) 13.4 140 11.9 84 1.13 0.87–1.45 .3606
CHF (4280) 10.2 106 6.7 47 1.52 1.09–2.12 .0114
2002
Atrial fibrillation (42731) 13.0 102 10.5 91 1.13 0.98–1.31 .1028
CHF (4280) 9.2 72 7.5 65 1.12 0.95–1.33 .2018
COPD, Chronic obstructive pulmonary disease; CAD, coronary artery disease; PVD, peripheral vascular disease; CHF, congestive heart failure; CI, confidence
interval.
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LOS for endovascuar procedures across all 3 years was
approximately 3.6 days, and the median was 2 days. By
comparison, the mean LOS for open procedures was be-
tween 9.9 and 10.6 days for all 3 years, with a median of 7
days. The difference between the procedures was statisti-
cally significant (P  .0001).
The LOS data, which include all people operated on
regardless of the outcome of their surgery, indicate that
nearly 30% of all patients who underwent endovascular
repair were discharged in24 hours over the 3-year period,
whereas nearly 60% were discharged in less than 3 days. By
comparison, on average, 4% of patients who underwent
open AAA repair were discharged in less than 3 days for all
3 years combined. Moreover, approximately 60% of all
patients who underwent open procedures were hospital-
ized for 7 days or longer. For simplicity, Fig 5 depicts LOS
for both procedures in 2002. All three years had a very
similar distribution.
DISCUSSION
During the last 2 years there has been a significant
increase in the overall number of AAA repairs performed in
NYS, where almost 10% of national hospital inpatient dis-
charges occur. Although a number of factors may contrib-
ute to this increase, such as aging of the population, in-
crease in incidental discovery of AAA, growth of diagnostic
testing, and heightened public awareness of aneurysms, we
believe that the introduction of and reimbursement for
endovascular repairs may be a prominent factor. After dis-
semination of endovascular repair training programs and
introduction of the ICD-9 code for endovascular AAA
repair, there was a substantial increase in the usage rate per
capita for total AAA surgeries. This growth occurred mainly
in use of endovascular procedures. By 2002 more endovas-
cular repairs were being performed than open repairs, and
the use of this procedure had expanded across hospitals and
counties.
This pattern is reminiscent of epidemiologic changes in
rates of utilization for gallbladder surgery after introduc-
tion of laparoscopic cholecystectomy. The introduction of
laparoscopic gallbladder surgery resulted in an increase in
the overall rate of gallbladder procedures both by changing
the indications for intervention and by expanding the pa-
tient pool.20 Similarly, our data demonstrate the expanded
use of endovascular grafts in the elderly. Moreover, recipi-
ents of endovascular repair had a greater number of como-
bid conditions, with higher rates of hypertension, coronary
artery disease, diabetes mellitus, and hyperlipidemia, com-
pared with recipients of open repair. These data suggest
that use of endovascular procedures has expanded among
older and sicker patients. Within the age group 75 years and
older, we noted a 31% per capita increase in use of endo-
vascular procedures from 2001 to 2002, with a nearly 27%
per capita decrease in open repairs. Although the highest
per capita rate of endovascular repair is in patients older
than 75 years, it is interesting to note that minimally
invasive techniques have not been restricted to the elderly
and the infirm, as may have been anticipated.
In 2002 female patients were still more likely to un-
dergo open aneurysm repair; only 43% of interventions
were performed with endovascular grafts. This is compared
with a utilization rate of 55% in males during the same
period. It is widely accepted that endovascular aneurysm
repair is more technically challenging in women, because of
the smaller size of the iliac vessels and challenging neck
anatomy. Despite this, the observed rate of use in women
was higher than many would have anticipated. Newer gen-
eration devices that are lower in profile will likely increase
the use of endovascular repair in female patients.
Although risk adjustment in administrative datasets is
difficult, our analysis indicates that patients who underwent
endovascular repair had more preoperative comorbid con-
ditions. Despite the higher severity of illness in patients
undergoing endovascular repair, in-hospital mortality for
this type of repair and postoperative complications were
significantly lower than for open repair in NYS. The endo-
vascular in-hospital mortality rate was about 1%. Because
our dataset reports only in-hospital mortality rates, rather
than 30-day mortality rate, comparison with the literature
is difficult. The mortality rate for endovascular repair re-
ported in single and multicenter clinical trials ranges from
0.6% to 9%.1,21 The reason for this tremendous variability
may be related to noncomparability of patients, ie, a differ-
ent degree of risk or difficulty of the repair. A substantial
number of investigators have reported rates for mortality
Fig 4. In-hospital mortality after abdominal aortic aneurysm re-
pair. Black bars, Open repairs; white bars, endovascular repairs.
Fig 5. Length of stay, 2002. Short,1 to3 days; Medium,3 to
7 days; Long, 7 days. Black bars, Open repairs; white bars,
endovascular repairs.
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and morbidity that are equivalent to those for open re-
pair.11-13 Our data, however, suggest that endovascular
aneurysm repair can be broadly applied, with excellent early
outcomes. These encouraging outcomes were achieved
despite use of endovascular repair in a sicker patient cohort
and its expanded use in nonacademic centers.
Despite the higher prevalence of comorbid conditions
and elderly patients among those undergoing endovascular
repair, LOS was significantly lower for these patients com-
pared with patients undergoing open procedures. There
was a marked difference in LOS between these two proce-
dures. On average, approximately 60% of patients who
underwent endovascular repair were discharged in less than
72 hours, whereas the same percentage of patients who
underwent open repair were hospitalized for 7 days or
longer. LOS is an important component of hospital costs,
and these data suggest a potential economic benefit from
endovascular repair. However, the net cost of endovascular
aneurysm repair also depends on the cost of the graft itself,
which has remained high; the need for lifelong surveillance;
and the potential need for repeat intervention. Several
studies have indicated that the potential savings in hospital
time may not outweigh these other costs.22-26 These vari-
ables could not be considered in our dataset.
Use of hospital discharge abstracts from secondary
sources, such as SPARCS, for epidemiologic research has
limitations. First, although these data contain associated
diagnoses, they do not contain sufficient information to
substantiate these diagnoses, nor do they provide sufficient
physiologic data (eg, blood pressure or left ventricular
ejection fraction) to accurately characterize the severity of
associated illnesses. Moreover, this dataset contains no
information on the size and characteristics of the aneurysm
itself. Second, these data typically do not identify the time
of onset of associated diseases, which sometimes makes it
difficult to differentiate between preexisting conditions and
postoperative complications. There may also be substantial
variation in reporting precision. A body of evidence con-
cerning the accuracy of administrative datasets highlights
the high rate of specificity and relatively low rate of sensi-
tivity for some comorbid illnesses.27,28 Smoking and obe-
sity, both of which have ICD-9 codes, typically have high
false negative rates of pickup in databases such as SPARCS.
From 2000 through 2002, a mere 4% to 8% of patients with
AAAs were recorded as having a history of smoking in the
SPARCS dataset. This is in sharp contrast to the rate of
smoking among the aneurysm population identified in
comparative studies, which is as high as 78% to 85%.12,29
Finally, we did not have access to patient or surgeon
identifiers; thus we were unable to calculate risk-adjusted
mortality or conduct volume-outcome analyses. An addi-
tional limitation of this type of dataset for comparison
between endovascular and open repair is that the common
complications associated with open repair (eg, pulmonary,
cardiac) are frequently coded, whereas complications that
typically are associated with endovascular repair (eg, ele-
vated serum creatinine level, dialysis, graft occlusion) are
not. At the same time, several studies have argued that
hospital discharge datasets are accurate in determining
primary diagnoses, especially of surgical procedures like
aneurysm repairs, because professional coders have an in-
centive to capture all high-reimbursement procedures.30 In
addition, these datasets do not suffer from the selection bias
imposed by patient or provider refusal to participate in a
study.31 However, risk-adjustment, necessary in making
comparisons in non-randomized studies, is not adequately
supported by these datasets. Thus, studies based on these
datasets are generally considered hypothesis generating
rather than confirmatory.
The diffusion of endovascular repair in NYS raises some
interesting questions. For open aneurysm repair, previous
research has established that mortality is diminished at
“high volume” centers, where more than 30 procedures are
performed annually.32,33 It would be of interest to deter-
mine whether a similar threshold is present for endovascu-
lar aneurysm repair. In 2002, 60 hospitals in NYS per-
formed endovascular repairs. Twenty percent performed
more than 30 endovascular aneurysm repairs per year, while
Table III. Postoperative complications
COMPLICATION
(ICD-9)
Open Endovascular
Relative
risk 95% CI P% n % n
2000 N  1237 N  131
Hemorrhage (2851) 11.4 141 3.8 5 2.98 1.25–7.15 .0076
Pulmonary (5185) 6.8 84 0.8 1 8.89 1.25–63.31 .0066
Cardiac (9971) 6.9 85 3.1 4 2.25 0.84–6.03 .0924
2001 N  1043 N  704
Hemorrhage (2851) 8.1 85 3.0 21 2.73 1.71–4.36 .0001
Pulmonary (5185) 7.5 78 1.6 11 4.78 2.56–8.93 .0001
Cardiac (9971) 8.1 84 2.7 19 2.98 1.83–4.86 .0001
2002 N  783 N  871
Hemorrhage (2851) 12.3 96 3.2 28 1.72 1.54–1.92 .0001
Pulmonary (5185) 9.3 73 1.4 12 1.90 1.71–2.10 .0001
Cardiac (9971) 7.8 61 3.3 29 1.47 1.26–1.71 .0001
CI, Confidence interval.
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in nearly 50% of the institutions fewer than 5 endovascular
procedures were performed per year. In this latter group of
hospitals, the crude mortality rate was more than double
(1.9% vs 0.8%) that in higher volume hospitals; however,
this difference (1.1%) was not statistically significant. Fur-
thermore, this analysis does not adequately correct for
differences in risk factors among patients at the different
institutions, nor does it capture readmissions and repeat
operations. Volume-outcome studies in other fields suggest
that large-volume centers often treat sicker patient popula-
tions. Finally, because of the small volume of procedures
performed annually in some institutions, such analysis must
include several years of experience at each institution and
also explore the existence of a learning curve phenomenon.
Our analysis demonstrates that endovascular appears to
be rapidly replacing open aneurysm repair, which is in
striking contrast to the lower rate of usage many predicted
when these devices were first released. There was initially a
general consensus that endovascular repair should be con-
fined to the elderly and infirm. However, 3 years after the
introduction of this technique, more than half of patients
receiving aneurysm repair in NYS were treated endovascu-
larly. Although endovascular repair is being offered to older
and sicker patients, this technique is also widely used in
younger patients who are excellent candidates for open
surgical repair. With the introduction of new generation
grafts with expanded applicability, the prevalence of endo-
vascular repair will most certainly increase. Recently the
results of two large trials have led to the recommendation
that AAA repair be reserved for patients whose aneurysms
exceed a diameter of 5.5 cm.34,35 The mortality rates
observed in these trials were 3.0% and 5.5%. Decisions
regarding the indications for intervention are often predi-
cated on a comparison of risk versus benefit. If future
studies, using longitudinal datasets, demonstrate that en-
dovascular aneurysm repair can be performed routinely
with a mortality rate of 1%, reevaluation of the threshold for
aneurysm repair may be appropriate. Decreased mortality
associated with the repair of AAAs will also further enhance
the already compelling data that support AAA screening.
Our findings are early and are based on 2 years of
diffusion of endovascular repairs. They will require broader
experience to substantiate a trend. It should also be empha-
sized that our data do not address the longer-term issues of
surveillance and repeat intervention, which are so critically
important in these patients. Nor do our data provide a
direct comparison of center outcomes because of limita-
tions in supporting risk-adjusted measurements. Our find-
ings are interesting, however, and suggest that endovascu-
lar techniques are diffusing rapidly with excellent early
outcomes. Confirmation of these trends requires prospec-
tive collection of clinical data, with detailed information on
patient characteristics. Large-scale or regional studies of
this sort would require the establishment of consortia of
hospitals to collect clinical data or society-based registries.
In this new era of treatment of aneurysm repair, the use of
statewide discharge datasets, confirmed by detailed clinical
studies, offers surgeons and policy makers the much-
needed information to continuously improve the quality of
care for patients with vascular disease.
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DISCUSSION
Dr Jon S. Matsumura (Chicago, Ill). I enjoyed the study. I
think it’s very important, because you’ve shown a reduction in
mortality with the endovascular compared with open repair in a
pretty large dataset.
In studies that I am familiar with, more than two thirds of the
early deaths after endovascular repair occur after the patient goes
home, so they are no longer inpatients. Because the deaths happen
within 30 days, they are counted as surgical.
Can you adjust the mortality rate in your endovascular group
to account for the shorter length of stay? Can you compare it with
a similar time period for the open? Do you have a 30-day mortality
rate for the endo and open groups?
Dr Patrice L. Anderson. We are unable to estimate a 30-day
mortality rate; we can only estimate in-hospital mortality. Our
access to the New York State dataset (SPARCS) did not include
patient identifiers; consequently we were unable to follow re-
hospitalizations or evidence of deaths out of the hospital. It is
important to reemphasize that we have only analyzed in-hospital
mortality rates for this presentation.
Dr Satish C. Muluk (Pittsburgh, Pa). I have two questions
for you. Do you think the differences between endovascular and
open mortality results could be related to the difference in the type
of aneurysms being done among the open patients in this time
period? And second, the increase in numbers that you saw over the
time period, could that have any connection with patients being
sent in from out of state to the big centers in New York that would
be doing endovascular repair during this period?
Dr. Anderson. I fully agree with your first statement. It may
be that the patients who are getting open repair have technically
difficult anatomy and that they were not candidates for endovas-
cular repair because of the complexity of their case. The type of
aneurysm and the technical difficulty are clinical details that are not
available in large administrative datasets such as SPARCS.
I also agree with the second statement. Patients may have
migrated into New York State to the centers capable of doing
endovascular repair. What we found is that centers performing
endovascular repairs did approximately 60% of the open cases in
2000, but by 2002 they were doing about 78% of the open
repairs. This may indicate that there is some concentration of
open repairs in the institutions that are capable of endovascular
intervention.
Dr Richard M. Green (Rochester, NY). That was nicely
presented, and I appreciate your sending me the manuscript.
I think these results are of critical importance, because they
show that with the introduction of the new technology, and no
basis of past experience, community-based surgeons can already
get better results than with conventional therapy. And I think
you’re to be congratulated for bringing this to our attention.
Many of us have criticized the 1-day, 2-day training programs,
but clearly they work. Can you tell us more about the learning
curve though? I’d be very interested to know, on day 1 are the
results as good as at year 5 of experience?
Dr Anderson. From our current data I am unable to conduct
a longitudinal analysis of how many cases an institution has done in
total, but that would be very interesting for us to look at in the
future.
I can say that the smaller volume centers, performing one to
five cases per year in 2002, have a comparable mortality rate to the
teaching institutions and the centers doing a large number of cases.
The relationship of volume to outcome is always a very inter-
esting and intriguing concept. A challenge with this dataset is that
we do not have patient identifiers, which would be needed to
adequately adjust for preexisting medical conditions. Conse-
quently, we do not have the basis to say that the mortality at the
community level is the same, better, or worse than the rate in a
teaching institution, because there may be sicker patients going to
the teaching institutions, or vice versa. Though we did look at the
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